Lifevantage Corporation Common Stock (Delaware) LFVN
Analyst Ratings
- Consensus
- Moderate Buy — 1 Buy · 1 Hold · 0 Sell (2 analysts)
- Avg. Price Target
- $8.50 (+62.8% upside)
Key Stats
- Today's Range
- $5.09 – $5.32
- 50-Day Range
- $5.05 – $6.76
- 52-Week Range
- $3.90 – $11.71
- Volume
- 24K shs
- Average Volume
- 27K shs
- Market Cap
- $65.72 million
- P/E Ratio
- —
- Dividend Yield
- 3.83%
Dividend
- Dividend Yield
- 3.83%
- Annual Dividend
- $0.20
- Payout Ratio
- —
- Ex-Dividend Date
- 2026-09-01
Short Interest
- Short Interest
- 0.87%
- Days to Cover
- 3.91
About Lifevantage Corporation Common Stock (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product. Geographically, its products are sold in the regions of in the United States, Mexico, Canada, Japan, Taiwan, Thailand, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, Austria, Spain, Ireland, Belgium and Others. The company operates in a single operating segment by selling products directly to customers through an international network of independent consultants that operate in an integrated manner.
Related Stocks
Compare head-to-head: LFVN vs LLY·LFVN vs JNJ·LFVN vs ABBV·LFVN vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.